Partners Group Holding Ag Mersana Therapeutics, Inc. Transaction History

Partners Group Holding Ag

  • $1.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$2.84 - $5.0 $106,423 - $187,365
37,473 New
37,473 $173,000
Q1 2021

May 14, 2021
SELL
$15.31 - $26.52 $625,826 - $1.08 Million
-40,877 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$16.84 - $27.59 $14,212 - $23,285
-844 Reduced 2.02%
40,877 $1.09 Million
Q3 2020

Nov 12, 2020
BUY
$16.2 - $25.7 $675,880 - $1.07 Million
41,721 New
41,721 $777,000

Others Institutions Holding MRSN

# of Institutions
125
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $74.8M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Partners Group Holding Ag Portfolio

Follow Partners Group Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Group Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Partners Group Holding Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email